ricerca
avanzata

Multiple Sclerosis Therapeutics - 9780521766272

Un libro in lingua di Cohen Jeffrey A. M.D. (EDT) Rudick Richard A. M.D. (EDT) edito da Cambridge Univ Pr, 2011

  • € 246.30
  • Il prezzo è variabile in funzione del cambio della valuta d’origine

Cohen and Rudick (multiple sclerosis treatment and research, Cleveland Clinic) bring together 62 chapters that review the current state of clinical trial methods in multiple sclerosis treatment, for practitioners, investigators, and clinical trial sponsors. Neurologists, neuroscientists, and other specialists from North America, Europe, and Japan address trial methodology, including physical and quality of life assessment, imaging outcomes, biological markers, ethics, and developments in regulatory review; specific trials of therapies; and therapy in clinical practice to manage MS, fatigue, spasticity, bladder and sexual dysfunction, depression, pain disorders, and other aspects. This edition has been revised to add new material on cortical lesions and has updates on genetics, magnetic resonance imaging and other endpoints, drug mechanism of action and adverse effects, and neuroprotection and repair strategies. It has 15 new chapters on pathology, epidemiology, gray matter imaging, medical comorbidities, chronic cerebrospinal venous insufficiency, new oral and monoclonal antibody therapies, mesenchymal and neural stem cell transplantation, diagnosis and treatment of neuromyelitis optica, and pediatric onset. Annotation ©2012 Book News, Inc., Portland, OR (booknews.com)

Informazioni bibliografiche